Mortgage & Property

New Insurance Professional

Family Office Bulletin

Mortgage Property

Insurance Professional

Family Office

Renalytix AI losses widen as it progresses development programme

Artificial intelligence (AI) diagnostics company Renalytix AI recorded $0.4m (£0.29m) of pharmaceutical services revenue in its first half, it announced on Tuesday.
The AIM-traded firm said the cost of revenue for the six months ended 31 December was $0.2m.

Its operating expenses totalled $14m, up from $5m year-on-year, while general and administrative expenses increased due to a $2.8m rise in compensation and related benefits due to increased headcount, a $2.2m increase in insurance costs, a $1.6m increase in legal and accounting fees due to Securities and Exchange Commission filings and U.S. public listing compliance, a $0.4m increase in consulting and professional fees, a $0.3m rise in recruiting expenses, and an increase of $0.2m in marketing, facility and other operating expenses.

Research and development-related expenses were $1.5m higher, the firm said, due to increased headcount and the associated compensation and related benefits, including share-based payments.

Those increases came as the company continued to develop its core technology and prepared for expanded clinical operations with Mount Sinai and additional health care system partnership programmes, and two development studies focused on the long-term effects of Covid-19 on kidney health, the board explained.

Its net loss before tax was $16.2m for the six months ended 31 December, including one-time charges and extraordinary expenses, widening from $6.3m for the first half of the 2020 financial year.

Cash, cash equivalents and short-term investments totalled $74.5m at period end.

“Our path to establishing advanced precision prognostics to guide and inform population-wide kidney health continues to become clearer,” said chief executive officer James McCullough.

“The January finalisation of the Medicare Coverage of Innovative Technology rule provides the foundation to achieve broad insurance coverage for ‘KidneyIntelX’.”

McCullough said that, with the firm’s newly-announced partnerships with University of Utah and DaVita, it was “on track” to exceed its goal of implementing KidneyIntelX across at least three major healthcare networks before its fiscal year ends in June.

“We expect to announce additional partnerships in 2021 that will further set the foundation for direct access to KidneyIntelX in advance of Medicare coverage by large groups of primary care and specialist clinicians treating early stage diabetic kidney disease patients.”

At 1111 GMT, shares in Renalytix AI were up 3.51% at 885p.

This Week’s Most Read

  • An interview with the pub landlord that barred Sir Keir Starmer

    Footage from today shows Sir Keir Starmer’s entourage man handling Rod Humphris, pub landlord for the Raven of Bath Public house. In this exclusive interview,

  • Sir Keir Starmer in pub brawl?

    Predictions of scuffles in pubs came true today, with a landlord being ejected from his own pub by interlopers. Sir Keir Starmer had been listening

  • Haatch SEIS fund oversubscribed within 2 weeks

    Haatch Ventures quietly launched their first SEIS Fund in March, with a target raise of £1.5m.  This figure was reached within 2 weeks, and the

  • Sir Keir Starmer, pubs and COVID – taking the piss, not taking a piss..

    We thought you weren’t allowed into pubs these days? Incredible scenes erupted today outside the Raven Pub in Bath, as Sir Keir Starmer was confronted

  • Why Government support means there has never been a better time for sustainability start-ups

    When Glasgow hosts the United Nations Climate Change Conference in November, it will be more than two years since the UK signed into law its

  • Staycation Boom Could be Taxing for Landlords

    Furnished holiday lets offer tax breaks, but owners need to tread carefully. Soaring demand for holiday lets as the UK plans for a ‘staycation summer’

  • New financial advice service from Vanguard aimed at retirement savers

    Designed for investors saving for retirement, Vanguard Personal Financial Planning launches on the award-winning Vanguard UK Personal Investor platform – vanguardinvestor.co.uk/financial-advice. The service offers personalised

  • MainStreet Partners: does the ‘S’ in ESG have ‘middle child’ syndrome?

    Long overlooked in favour of its more obvious counterparts, last year saw investors turn a corner and beckon in ‘an era of social impact investing’,

  • Creating a sustainable future – A special supplement in conjunction with M&G | April 2021

    M&G Investments are one of the early adopters of ESG (environmental, social and governance) and impact investing strategies within their funds. In this IFA Magazine

  • The Coming Decade for Climate Solutions

    Randeep Somel, Fund Manager, M&G Climate Solutions Fund, is finding reasons to be cheerful as he uncovers some of the powerful drivers of change which

IFA Magazine

Keep updated on the most important financial events 

Make sure you are an informed

wealth professional..

Adblock Blocker

We have detected that you are using

adblocking plugin in your browser. 

IFA Magazine